Enter assignee name

% Expired Patents = 54.5

EPO Patents = 1

Forward Citations = 42

Loading Chart...

7 inventors (with patents filed for the assignee):

Jang-Yen Wu (6 out of 7 patents)

Herbert Weissbach (5 out of 14 patents)

Howard Malcolm Prentice (5 out of 7 patents)

4. David Binninger (2 out of 4 patents)

5. Lionel Resnick (2 out of 5 patents)

6. Nathan Brot (2 out of 7 patents)

7. Janet C Blanks (1 out of 3 patents)

11 patents: Sort by Forward Citations

1. 12246074 - Granulocyte colony-stimulating factor (GCSF) gene therapy for treating neurological diseases (2025-03-11),

2. 11576945 - Treatment for ischemic stroke (2023-02-14),

3. 10945986 - Treatment for ischemic stroke (2021-03-16),

4. 10792260 - Retinopathy treatment (2020-10-06),

5. 10272063 - Treatment for ischemic stroke (2019-04-30),

6. 9827220 - Treatment for ischemic stroke (2017-11-28),

7. 9050305 - Treatment for ischemic stroke (2015-06-09),

8. 8871971 - Protection of normal cells (2014-10-28),

9. 8765808 - Treatment or prevention of cancer and precancerous disorders (2014-07-01),

10. 8603985 - Treatment or prevention of cancer and precancerous disorders (2013-12-10),

11. 8487128 - Protection of normal cells (2013-07-16),

Chs Pharma, Inc. is a leading pharmaceutical company specializing in the research, development, and manufacturing of innovative healthcare products. With a commitment to quality and customer satisfaction, Chs Pharma delivers cutting-edge solutions to address the needs of patients and healthcare professionals worldwide.

Profile summary based on public USPTO records.